Novus FC Hydrating Cream
Novus FC Hydrating Cream by Aauris Healthcare is a dermatologically safe, non-comedogenic moisturiser made with an advanced formula of ceramides, arbutin and allantoin. The lightweight cream helps restore the skin barrier, locks in moisture and keeps the skin soft, smooth and comfortably hydrated through the day. It is hypo-allergenic, free of parabens and sulphates, and suitable for all skin types, including sensitive and acne-prone skin. It comes in a 100 ml pump bottle for easy, hygienic dispensing.
Key Features
- Advanced formula with ceramides, arbutin and allantoin
- Non-comedogenic and hypo-allergenic
- Skin-friendly pH and suitable for all skin types
- Free from parabens and sulphates
- 100 ml pump bottle for hygienic dispensing
Key Benefits
- Provides intense, long-lasting hydration
- Helps restore and strengthen the skin barrier
- Supports skin elasticity and a smoother texture
- Helps brighten the look of dull skin
- Gentle enough for daily use on the face and body
How to Use
- Shake the bottle well before use
- Dispense a suitable amount onto the palm
- Apply evenly on clean skin and massage gently until absorbed
- Use daily, or as directed by your dermatologist
Storage & Manufacturing
Store in a cool, dry place away from direct sunlight. Marketed by Aauris Healthcare Private Limited, India. Net volume: 100 ml.
Safety Advice
For external use only. Avoid contact with the eyes; if contact occurs, rinse thoroughly with water. Do a patch test on a small area before first use, and stop using the product if redness, itching or irritation develops. Keep out of reach of children. Consult a dermatologist if your skin condition persists or worsens.
Disclaimer
The information provided is for general reference only and is not a substitute for professional medical advice. Individual results may vary. Please consult a qualified doctor or dermatologist before using this product, especially if you have a skin condition, are pregnant or are breastfeeding.
















Reviews
There are no reviews yet.